MG-1131 is a human monoclonal antibody (mAb) targeting TIGIT. It activates NF-kappaB signaling in T cells and enhances NK cell-mediated tumor-killing activity in a PVR-dependent manner. By blocking TIGIT, MG-1131 increases IFN-gamma secretion. This compound is applicable for research in antitumor immunity. Recommended isotype control: HumanIgG1kappa, Isotype Control.
Target-Kategorie:
NF-kappaB|||Others|||IFNAR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
